Literature DB >> 17468339

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.

Blanche P Alter1, Gabriela M Baerlocher, Sharon A Savage, Stephen J Chanock, Babette B Weksler, Judith P Willner, June A Peters, Neelam Giri, Peter M Lansdorp.   

Abstract

Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome in which the known susceptibility genes (DKC1, TERC, and TERT) belong to the telomere maintenance pathway; patients with DC have very short telomeres. We used multicolor flow fluorescence in situ hybridization analysis of median telomere length in total blood leukocytes, granulocytes, lymphocytes, and several lymphocyte subsets to confirm the diagnosis of DC, distinguish patients with DC from unaffected family members, identify clinically silent DC carriers, and discriminate between patients with DC and those with other bone marrow failure disorders. We defined "very short" telomeres as below the first percentile measured among 400 healthy control subjects over the entire age range. Diagnostic sensitivity and specificity of very short telomeres for DC were more than 90% for total lymphocytes, CD45RA+/CD20- naive T cells, and CD20+ B cells. Granulocyte and total leukocyte assays were not specific; CD45RA- memory T cells and CD57+ NK/NKT were not sensitive. We observed very short telomeres in a clinically normal family member who subsequently developed DC. We propose adding leukocyte subset flow fluorescence in situ hybridization telomere length measurement to the evaluation of patients and families suspected to have DC, because the correct diagnosis will substantially affect patient management.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17468339      PMCID: PMC1975834          DOI: 10.1182/blood-2007-02-075598

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation.

Authors:  N Rufer; T H Brümmendorf; B Chapuis; C Helg; P M Lansdorp; E Roosnek
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

2.  Telomere length changes in patients with aplastic anaemia.

Authors:  J J Lee; H Kook; I J Chung; J A Na; M R Park; T J Hwang; J Y Kwak; S K Sohn; H J Kim
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

Review 3.  Shwachman-Diamond syndrome: report from an international conference.

Authors:  Robert Rothbaum; Jean Perrault; Adrianna Vlachos; Marco Cipolli; Blanche P Alter; Susan Burroughs; Peter Durie; M Tarek Elghetany; Richard Grand; Van Hubbard; Johanna Rommens; Thomas Rossi
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

Review 4.  Telomeres in T and B cells.

Authors:  Richard J Hodes; Karen S Hathcock; Nan-ping Weng
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

5.  Flow cytometry and FISH to measure the average length of telomeres (flow FISH).

Authors:  Gabriela M Baerlocher; Irma Vulto; Gary de Jong; Peter M Lansdorp
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  Abnormal telomere shortening in leucocytes of children with Shwachman-Diamond syndrome.

Authors:  Ian Thornley; Yigal Dror; Lilian Sung; Rob F Wynn; Melvin H Freedman
Journal:  Br J Haematol       Date:  2002-04       Impact factor: 6.998

7.  Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita.

Authors:  T J Vulliamy; S W Knight; P J Mason; I Dokal
Journal:  Blood Cells Mol Dis       Date:  2001 Mar-Apr       Impact factor: 3.039

8.  Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease.

Authors:  H Gazda; J M Lipton; T N Willig; S Ball; C M Niemeyer; G Tchernia; N Mohandas; M J Daly; A Ploszynska; K A Orfali; A Vlachos; B E Glader; R Rokicka-Milewska; A Ohara; D Baker; D Pospisilova; A Webber; D H Viskochil; D G Nathan; A H Beggs; C A Sieff
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

9.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.

Authors:  T Vulliamy; A Marrone; F Goldman; A Dearlove; M Bessler; P J Mason; I Dokal
Journal:  Nature       Date:  2001-09-27       Impact factor: 49.962

Review 10.  Telomerase in the human organism.

Authors:  Kathleen Collins; James R Mitchell
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

View more
  162 in total

1.  Connecting complex disorders through biology.

Authors:  Sharon A Savage
Journal:  Nat Genet       Date:  2012-02-27       Impact factor: 38.330

2.  Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita.

Authors:  Marjolijn C J Jongmans; Eugene T P Verwiel; Yvonne Heijdra; Tom Vulliamy; Eveline J Kamping; Jayne Y Hehir-Kwa; Ernie M H F Bongers; Rolph Pfundt; Liesbeth van Emst; Frank N van Leeuwen; Koen L I van Gassen; Ad Geurts van Kessel; Inderjeet Dokal; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg; Roland P Kuiper
Journal:  Am J Hum Genet       Date:  2012-02-16       Impact factor: 11.025

3.  Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths.

Authors:  Masayuki Kimura; Rivka C Stone; Steven C Hunt; Joan Skurnick; Xiaobin Lu; Xiaojian Cao; Calvin B Harley; Abraham Aviv
Journal:  Nat Protoc       Date:  2010-09-02       Impact factor: 13.491

4.  Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; June A Peters; Jennifer T Loud; Lisa Leathwood; Ann G Carr; Mark H Greene; Philip S Rosenberg
Journal:  Br J Haematol       Date:  2010-04-30       Impact factor: 6.998

Review 5.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

Review 6.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

Review 7.  Neonatal manifestations of inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Fetal Neonatal Med       Date:  2015-12-24       Impact factor: 3.926

8.  Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia.

Authors:  Hirotoshi Sakaguchi; Nobuhiro Nishio; Asahito Hama; Nozomu Kawashima; Xinan Wang; Atsushi Narita; Sayoko Doisaki; Yinyan Xu; Hideki Muramatsu; Nao Yoshida; Yoshiyuki Takahashi; Kazuko Kudo; Hiroshi Moritake; Kazuhiro Nakamura; Ryoji Kobayashi; Etsuro Ito; Hiromasa Yabe; Shouichi Ohga; Akira Ohara; Seiji Kojima
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

Review 9.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

10.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.